Ganesh Bavikatte
Hat mitgewirkt an:
-
High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study
-
Long‐term observational results from the ASPIRE study: onabotulinumtoxinA treatment for adult lower limb spasticity
-
Pain, disability, and quality of life in participants after concurrent onabotulinumtoxinA treatment of upper and lower limb spasticity: Observational results from the ASPIRE study